Open-label, ascending dose trial of ACTUS-101 administered intravenously.
Age: 18 years - 66+
Gender: All
We've found 1 total result for "Glycogen Storage Disease Type II".
We've found 1 total result for "Glycogen Storage Disease Type II".
Open-label, ascending dose trial of ACTUS-101 administered intravenously.
Age: 18 years - 66+
Gender: All